Free Trial
→ I was right about SpaceX (From Brownstone Research) (Ad)tc pixel Free SKIN Stock Alerts

Beauty Health (SKIN) Competitors

Beauty Health logo
$0.61 0.00 (-0.44%)
Closing price 06/5/2026 04:00 PM Eastern
Extended Trading
$0.61 0.00 (-0.10%)
As of 06/5/2026 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

SKIN vs. CLPT, DCTH, CNXU, CV, and CARL

Should you buy Beauty Health stock or one of its competitors? MarketBeat compares Beauty Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Beauty Health include ClearPoint Neuro (CLPT), Delcath Systems (DCTH), Conexeu Sciences (CNXU), CapsoVision (CV), and Carlsmed (CARL). These companies are all part of the "medical equipment" industry.

How does Beauty Health compare to ClearPoint Neuro?

ClearPoint Neuro (NASDAQ:CLPT) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.

30.1% of ClearPoint Neuro shares are owned by institutional investors. Comparatively, 93.3% of Beauty Health shares are owned by institutional investors. 6.9% of ClearPoint Neuro shares are owned by insiders. Comparatively, 40.3% of Beauty Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Beauty Health has higher revenue and earnings than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ClearPoint Neuro$36.97M10.46-$25.54M-$1.01N/A
Beauty Health$300.80M0.26-$9.52M-$0.17N/A

ClearPoint Neuro presently has a consensus target price of $18.00, indicating a potential upside of 39.64%. Beauty Health has a consensus target price of $2.02, indicating a potential upside of 232.46%. Given Beauty Health's higher probable upside, analysts clearly believe Beauty Health is more favorable than ClearPoint Neuro.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ClearPoint Neuro
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Beauty Health
1 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

ClearPoint Neuro has a beta of 1.31, meaning that its stock price is 31% more volatile than the broader market. Comparatively, Beauty Health has a beta of 1.09, meaning that its stock price is 9% more volatile than the broader market.

In the previous week, Beauty Health had 10 more articles in the media than ClearPoint Neuro. MarketBeat recorded 12 mentions for Beauty Health and 2 mentions for ClearPoint Neuro. Beauty Health's average media sentiment score of 0.99 beat ClearPoint Neuro's score of -0.07 indicating that Beauty Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ClearPoint Neuro
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Beauty Health
8 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Beauty Health has a net margin of -2.03% compared to ClearPoint Neuro's net margin of -71.57%. Beauty Health's return on equity of -9.38% beat ClearPoint Neuro's return on equity.

Company Net Margins Return on Equity Return on Assets
ClearPoint Neuro-71.57% -140.96% -36.98%
Beauty Health -2.03%-9.38%-1.21%

Summary

Beauty Health beats ClearPoint Neuro on 12 of the 16 factors compared between the two stocks.

How does Beauty Health compare to Delcath Systems?

Beauty Health (NASDAQ:SKIN) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings, analyst recommendations and media sentiment.

Delcath Systems has lower revenue, but higher earnings than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beauty Health$300.80M0.26-$9.52M-$0.17N/A
Delcath Systems$85.23M4.32$2.70M$0.011,067.00

Beauty Health currently has a consensus target price of $2.02, indicating a potential upside of 232.46%. Delcath Systems has a consensus target price of $22.50, indicating a potential upside of 110.87%. Given Beauty Health's higher probable upside, research analysts clearly believe Beauty Health is more favorable than Delcath Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beauty Health
1 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Delcath Systems
2 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.43

In the previous week, Beauty Health had 12 more articles in the media than Delcath Systems. MarketBeat recorded 12 mentions for Beauty Health and 0 mentions for Delcath Systems. Beauty Health's average media sentiment score of 0.99 beat Delcath Systems' score of 0.00 indicating that Beauty Health is being referred to more favorably in the media.

Company Overall Sentiment
Beauty Health Positive
Delcath Systems Neutral

Beauty Health has a beta of 1.09, meaning that its stock price is 9% more volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market.

Delcath Systems has a net margin of 0.62% compared to Beauty Health's net margin of -2.03%. Delcath Systems' return on equity of 0.51% beat Beauty Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Beauty Health-2.03% -9.38% -1.21%
Delcath Systems 0.62%0.51%0.46%

93.3% of Beauty Health shares are owned by institutional investors. Comparatively, 61.1% of Delcath Systems shares are owned by institutional investors. 40.3% of Beauty Health shares are owned by insiders. Comparatively, 19.4% of Delcath Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Delcath Systems beats Beauty Health on 9 of the 16 factors compared between the two stocks.

How does Beauty Health compare to Conexeu Sciences?

Beauty Health (NASDAQ:SKIN) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation.

In the previous week, Beauty Health had 8 more articles in the media than Conexeu Sciences. MarketBeat recorded 12 mentions for Beauty Health and 4 mentions for Conexeu Sciences. Beauty Health's average media sentiment score of 0.99 beat Conexeu Sciences' score of 0.55 indicating that Beauty Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Beauty Health
8 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Conexeu Sciences
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Beauty Health currently has a consensus price target of $2.02, suggesting a potential upside of 232.46%. Given Beauty Health's stronger consensus rating and higher possible upside, analysts clearly believe Beauty Health is more favorable than Conexeu Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beauty Health
1 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Conexeu Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Conexeu Sciences has a net margin of 0.00% compared to Beauty Health's net margin of -2.03%. Conexeu Sciences' return on equity of 0.00% beat Beauty Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Beauty Health-2.03% -9.38% -1.21%
Conexeu Sciences N/A N/A N/A

Conexeu Sciences has lower revenue, but higher earnings than Beauty Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beauty Health$300.80M0.26-$9.52M-$0.17N/A
Conexeu SciencesN/AN/AN/AN/AN/A

93.3% of Beauty Health shares are owned by institutional investors. 40.3% of Beauty Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Beauty Health beats Conexeu Sciences on 8 of the 11 factors compared between the two stocks.

How does Beauty Health compare to CapsoVision?

CapsoVision (NASDAQ:CV) and Beauty Health (NASDAQ:SKIN) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

Beauty Health has a net margin of -2.03% compared to CapsoVision's net margin of -198.87%. CapsoVision's return on equity of 0.00% beat Beauty Health's return on equity.

Company Net Margins Return on Equity Return on Assets
CapsoVision-198.87% N/A -136.03%
Beauty Health -2.03%-9.38%-1.21%

CapsoVision presently has a consensus target price of $8.50, suggesting a potential upside of 18.22%. Beauty Health has a consensus target price of $2.02, suggesting a potential upside of 232.46%. Given Beauty Health's higher probable upside, analysts plainly believe Beauty Health is more favorable than CapsoVision.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CapsoVision
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50
Beauty Health
1 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

93.3% of Beauty Health shares are held by institutional investors. 2.3% of CapsoVision shares are held by company insiders. Comparatively, 40.3% of Beauty Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Beauty Health has higher revenue and earnings than CapsoVision. Beauty Health is trading at a lower price-to-earnings ratio than CapsoVision, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CapsoVision$13.55M26.51-$25.32M-$2.34N/A
Beauty Health$300.80M0.26-$9.52M-$0.17N/A

In the previous week, Beauty Health had 12 more articles in the media than CapsoVision. MarketBeat recorded 12 mentions for Beauty Health and 0 mentions for CapsoVision. Beauty Health's average media sentiment score of 0.99 beat CapsoVision's score of 0.00 indicating that Beauty Health is being referred to more favorably in the news media.

Company Overall Sentiment
CapsoVision Neutral
Beauty Health Positive

Summary

Beauty Health beats CapsoVision on 10 of the 15 factors compared between the two stocks.

How does Beauty Health compare to Carlsmed?

Beauty Health (NASDAQ:SKIN) and Carlsmed (NASDAQ:CARL) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

Beauty Health currently has a consensus target price of $2.02, indicating a potential upside of 232.46%. Carlsmed has a consensus target price of $19.33, indicating a potential upside of 74.65%. Given Beauty Health's higher possible upside, analysts plainly believe Beauty Health is more favorable than Carlsmed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Beauty Health
1 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Carlsmed
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

In the previous week, Beauty Health had 11 more articles in the media than Carlsmed. MarketBeat recorded 12 mentions for Beauty Health and 1 mentions for Carlsmed. Beauty Health's average media sentiment score of 0.99 beat Carlsmed's score of 0.00 indicating that Beauty Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Beauty Health
8 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Carlsmed
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

93.3% of Beauty Health shares are owned by institutional investors. 40.3% of Beauty Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Beauty Health has a net margin of -2.03% compared to Carlsmed's net margin of -57.76%. Beauty Health's return on equity of -9.38% beat Carlsmed's return on equity.

Company Net Margins Return on Equity Return on Assets
Beauty Health-2.03% -9.38% -1.21%
Carlsmed -57.76%-60.74%-29.84%

Beauty Health has higher revenue and earnings than Carlsmed. Carlsmed is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Beauty Health$300.80M0.26-$9.52M-$0.17N/A
Carlsmed$50.51M5.96-$29.63M-$2.51N/A

Summary

Beauty Health beats Carlsmed on 12 of the 15 factors compared between the two stocks.

Get Beauty Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for SKIN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SKIN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SKIN vs. The Competition

Export
MetricBeauty HealthMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$78.74M$8.70B$6.68B$11.99B
Dividend YieldN/A1.76%2.67%5.55%
P/E Ratio-3.5722.2924.0623.63
Price / Sales0.2620.38516.17112.44
Price / Cash3.9888.4542.2354.60
Price / Book1.275.209.736.35
Net Income-$9.52M$175.77M$3.57B$337.59M
7 Day Performance-21.48%-2.20%-1.28%-2.52%
1 Month Performance-33.23%7.06%1.38%-0.03%
1 Year Performance-62.03%3.44%23.93%25.34%

Beauty Health Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SKIN
Beauty Health
3.1942 of 5 stars		$0.61
-0.4%		$2.02
+232.5%		-62.0%$78.74M$300.80MN/A1,030
CLPT
ClearPoint Neuro
2.8624 of 5 stars		$12.09
-4.4%		$18.00
+48.9%		-7.5%$379.07M$40.61MN/A110
DCTH
Delcath Systems
1.927 of 5 stars		$10.49
-1.1%		$22.50
+114.6%		-34.9%$365.93M$90.44M1,049.9060
CNXU
Conexeu Sciences
N/A$15.65
+10.8%		N/AN/A$356.81MN/AN/A4
CV
CapsoVision
1.0254 of 5 stars		$6.90
+0.0%		$8.50
+23.2%		N/A$338.76M$13.56MN/A90

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SKIN) was last updated on 6/7/2026 by MarketBeat.com Staff.
From Our Partners
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel